Frankfurt (dpa-Afx)
Sartorius further recovered – quarterly figures better than expected
The papers of the laboratory supplier Sartorius benefited from quarterly figures on Wednesday. On Tradegate, the advantages listed in the DAX gained 4.3 percent to the Xetra closing to EUR 202.50, which would be likely to continue their recovery from the customs shock deep in Xetra trading more than a week ago. Last week, the share price had fallen to a five -year low at around 166 euros.
The numbers for the first annual quarter are better than expected, said a dealer. He emphasized the relationship between receipt of order to sales, which was very satisfactory with over 1. The margin view is also slightly better than expected.
In 2025, sales should increase by about 6 percent. Around 29 to 30 (previous year: 28.0) percent as an adjusted result before interest, taxes and depreciation (EBITDA) should get stuck from the turnover. Possible effects from tariffs are not included in the margin forecast./AJX/MIS
Selected leverage products on Sartorius VZ.
With knock-outs, speculative investors can participate disproportionately in price movements. Simply choose the desired lever and we show you suitable open-end products on Sartorius VZ.
The lever must be between 2 and 20
Advertising